There are only two reasons to stop a clinical trial in the middle, Bob Seevers, a former FDA reviewer, now a regulatory consultant, tells Outside Run
in 1985, at age 56, he suffered a fatal heart attack while running
Benefits of BPC-157 and the FDA's Concerns BPC-157, a peptide derived from a protein in the stomach, has been studied for its potential health benefits
This helps lower blood sugar levels but also helps reduce appetite, which can lead to weight loss
In clinical practice, she explained, physicians start low and raise the dose gradually in a process called titration, an approach that "balances treatment efficacy with side effects." Sometimes they intentionally keep someone at a lower, submaximal dose rather than pushing to the maximum